Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
disease | 0.500 | None | 1.000 | 37 | 2 | 2006 | 2019 | ||||||||
|
thrombopoietin | 0.513 | 0.692 | 0.20 |
|
disease | 0.500 | None | 0.969 | 29 | 0 | 1995 | 2020 | ||||||||
|
MPL proto-oncogene, thrombopoietin receptor | 0.510 | 0.692 | 4.1E-09 |
|
disease | 0.500 | None | 0.957 | 19 | 3 | 2004 | 2018 | ||||||||
|
calreticulin | 0.413 | 0.923 | 0.89 |
|
disease | 0.200 | None | 1.000 | 14 | 0 | 2014 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.090 | None | 1.000 | 8 | 0 | 1995 | 2019 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
disease | 0.170 | None | 1.000 | 7 | 0 | 1996 | 2019 | ||||||||
|
splicing factor 3b subunit 1 | 0.511 | 0.731 | 1.00 |
|
disease | 0.160 | None | 1.000 | 6 | 0 | 2013 | 2019 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2007 | 2019 | ||||||||
|
mucin 16, cell surface associated | 0.479 | 0.808 | 8.3E-112 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2017 | 2019 | ||||||||
|
microRNA 145 | 0.431 | 0.846 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2012 | |||||||||
|
microRNA 146a | 0.398 | 0.885 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2012 | |||||||||
|
nuclear factor, erythroid 2 | 0.628 | 0.577 | 0.67 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2005 | 2014 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
disease | 0.130 | None | 1.000 | 3 | 0 | 1986 | 2019 | ||||||||
|
von Willebrand factor | 0.408 | 0.885 | 3.2E-25 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2018 | 2020 | ||||||||
|
arginyl-tRNA synthetase 1 | 0.604 | 0.538 | 3.3E-08 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2008 | 2010 | ||||||||
|
thymidine phosphorylase | 0.495 | 0.769 | 1.2E-04 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2017 | ||||||||
|
cytochrome c oxidase subunit 8A | 0.400 | 0.846 | 0.12 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2008 | 2018 | ||||||||
|
Pulmonary disease, chronic obstructive, severe early-onset | 0.456 | 0.885 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | |||||||||
|
erythropoietin | 0.381 | 0.885 | 1.1E-02 |
|
disease | 0.030 | None | 1.000 | 2 | 0 | 2002 | 2013 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2001 | 2005 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2017 | ||||||||
|
synthesis of cytochrome C oxidase 2 | 0.479 | 0.846 | 7.5E-07 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2017 | ||||||||
|
CD177 molecule | 0.595 | 0.654 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2002 | 2003 | |||||||||
|
proline rich protein BstNI subfamily 1 (gene/pseudogene) | 0.621 | 0.692 | 8.4E-11 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
platelet derived growth factor receptor beta | 0.416 | 0.846 | 0.90 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 |